SEARCH · Engineering Papers
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Mr. Guit will be presenting EOS Aqua Mission Operations Status at the International Earth Science Constellation (ESC) Mission Operations Working Group (MOWG) Meeting at GSFC in December 2018.
General information regarding the current health and status of the EOS (Earth Observing System) Terra Spacecraft. Updates to activities accomplished since the last MOWG (Mission Operations Working Group) and future maneuver plans are included as well.
This presentation will introduce topics regarding EOS Aura status for the Earth Science Constellation Mission Operations Working Group (MOWG) at Toulouse, France.
This presentation provides mission operations status for the Earth Observing System (EOS) Aqua satellite for the past six-months (December 2018 through May 2019). It only contains information that is of interest to the International Earth Science Constellation (ESC) Mission Operations Working Group (MOWG) member missions. It will be presented at the bi-annual MOWG Meeting in Toulouse, France on Wednesday, June 5, 2019. These meetings have been occurring twice a year since the MOWG was formed in 2003.
Slide presentation regarding the current state of health of the Terra mission, subsystem status, fuel remaining, recent activities and upcoming plans.
This package presents the current health of the Terra mission, along with recent activities, status on documentation and plans for the recent future.
EOS Aura Mission Status to be presented at the Earth Science Constellation Mission Operations Working Group (MOWG) meeting planned as a virtual meeting from September 29 - October 2, 2020.
EOS Aura Mission Status to be presented at the TROPOMI-OMI Workshop meeting planned as a virtual meeting from October 26 - October 29, 2020.
Presents the current health of the Terra mission, along with recent activities, status on documentation and plans for the recent future.
This package presents the current health of the Terra mission, along with recent activities, status on documentation and plans for the recent future.
EOS Aura Mission Status to be presented at the ESC Mission Operations Working Group (MOWG) meeting planned as a virtual meeting from May 16 - May 19, 2022.
Nuclear Computational Resource Center's history, goals and objectives; main tasks to achieve goals and objectives; status, schedule and timeline; and FY21 Plans.
Presentation containing an update on the status of contracting for fuel fabrication in support of the MARVEL project.
Noise reduction remains an important priority in the modern society, in particular, for urban areas and highly populated cities. Insulation of buildings and transport systems such as cars, trains, and airplanes has accelerated the need to develop advanced materials. Various porous materials, such as commercially available foams and granular and fibrous materials, are commonly used for sound mitigating applications. In this review, a special class of advanced porous materials, aerogels, is examined, and an overview of the current experimental and theoretical status of their acoustic properties is provided. Aerogels can be composed of inorganic matter, synthetic or natural polymers, as well as organic/inorganic composites and hybrids. Aerogels are highly porous nanostructured materials with a large number of meso‐ and small macropores; the mechanisms of sound absorption partly differ from those of traditional porous absorbers possessing large macropores. The understanding of the acoustic properties of aerogels is far from being complete, and experimental results remain scattered. It is demonstrated that the structure of the aerogel provides a complex three‐dimensional architecture ideally suited for promising high‐performance materials for acoustic mitigation systems. This is in addition to the numerous other desirable properties that include low density, low thermal conductivity, and low refractive index.
Abstract In this Review, recent advances in the development of organic bipolar redox‐active molecules (BRMs) for redox‐flow batteries (RFBs) are discussed, with special emphasis on their utilization in non‐aqueous systems. BRMs are single molecules that can be used as both anolyte and catholyte. Their unique redox chemistry enables identical components to be present in RFBs, which has distinct advantages in storage, mitigating crossover and compound degradation. Recent scientific innovations have uncovered three main strategies in preparing these bipolar species: developing stable radicals that are capable of both positive and negative redox reactions, covalently bridging electron donor‐acceptor motifs on one single molecule, and forming biredox eutectic mixtures through physically mixing active components. These approaches not only enabled symmetric flow battery design, but also resulted in electroactive materials with improved properties such as solubility, stability, and cell voltage. Nevertheless, much is still to be done. Importantly, developing BRMs that are competitive with vanadium RFBs in all performance indicators (e. g. solubility >1.0 M, voltage output >2.0 V, and cycling longevity >10 000 cycles) remains a challenge. Mechanistic studies including molecular dynamics, plausible degradation processes, and electrode/solution interface are necessary to peer into key parameters that dominate their battery performance. Accordingly, we review the current status and suggest future opportunities in these areas.
Abstract Despite new antiseizure medications, the development of cholinergic‐induced refractory status epilepticus (RSE) continues to be a therapeutic challenge as pharmacoresistance to benzodiazepines and other antiseizure medications quickly develops. Studies conducted by Epilepsia . 2005;46:142 demonstrated that the initiation and maintenance of cholinergic‐induced RSE are associated with trafficking and inactivation of gamma‐aminobutyric acid A receptors (GABA A R) thought to contribute to the development of benzodiazepine pharmacoresistance. In addition, Dr. Wasterlain's laboratory reported that increased N‐methyl‐ d ‐aspartate receptors (NMDAR) and alpha‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptors (AMPAR) contribute to enhanced glutamatergic excitation ( Neurobiol Dis . 2013;54:225; Epilepsia . 2013;54:78). Thus, Dr. Wasterlain postulated that targeting both maladaptive responses of reduced inhibition and increased excitation that is associated with cholinergic‐induced RSE should improve therapeutic outcome. We currently review studies in several animal models of cholinergic‐induced RSE that demonstrate that benzodiazepine monotherapy has reduced efficacy when treatment is delayed and that polytherapy with drugs that include a benzodiazepine (eg midazolam and diazepam) to counter loss of inhibition, concurrent with an NMDA antagonist (eg ketamine) to reduce excitation provide improved efficacy. Improved efficacy with polytherapy against cholinergic‐induced seizure is demonstrated by reduction in (1) seizure severity, (2) epileptogenesis, and (3) neurodegeneration compared with monotherapy. Animal models reviewed include pilocarpine‐induced seizure in rats, organophosphorus nerve agent (OPNA)‐induced seizure in rats, and OPNA‐induced seizure in two mouse models: (1) carboxylesterase knockout (Es1 −/− ) mice which, similarly to humans, lack plasma carboxylesterase and (2) human acetylcholinesterase knock‐in carboxylesterase knockout (KIKO) mice. We also review studies showing that supplementing midazolam and ketamine with a third antiseizure medication (valproate or phenobarbital) that targets a nonbenzodiazepine site rapidly terminates RSE and provides further protection against cholinergic‐induced SE. Finally, we review studies on the benefits of simultaneous compared with sequential drug treatments and the clinical implications that lead us to predict improved efficacy of early combination drug therapies. The data generated from seminal rodent studies of efficacious treatment of cholinergic‐induced RSE conducted under Dr. Wasterlain's guidance suggest that future clinical trials should treat the inadequate inhibition and temper the excess excitation that characterize RSE and that early combination therapies may provide improved outcome over benzodiazepine monotherapy.
This paper provides a comprehensive assessment of the up-to-date life-cycle sustainability status of cadmium-telluride based photovoltaic (PV) systems. Current production modules (Series 6 and Series 7) are analyzed in terms of their energy performance and environmental footprint and compared with the older series 4 module production and current single-crystalline Silicon (sc-Si) module production. For fixed-tilt systems with Series 6 modules operating under average US irradiation of 1800 kWh/m 2 /year, the global warming potential (GWP) is reduced from 16 g CO 2eq /kWh in Series 4 systems to 10 CO 2 eq /kWh in Series 6 systems. For operation in US-SW irradiation of 2300 kWh/m 2 /year, the GWP is reduced from 11 to 8 CO 2eq /kWh and for 1-axis tracking systems operating in Phoenix, Arizona, with point-of array irradiation of 3051 kWh/m 2 /year the GWP is reduced to 6.5 CO 2eq /kWh. Similar reductions have happened in all environmental indicators. Energy payback times (EPBT) of currently installed systems range from 0.6 years for fixed–tilt ground–mounted installations at average US irradiation at latitude tilt installations to 0.3 years for one-axis trackers at high US-SW irradiation, considering average fossil-fuel dominated electricity grids with fuel to electricity conversion efficiency of 0.3. The resulting energy return on energy investment (EROI) also depends on the conversion efficiency of the electricity grid and on the operation life expectance. For a 30-year operational life and grid conversion efficiency of 0.3, EROI ranges from 50 (at US average irradiation) to 70 for US-SW irradiation. The EROI declines with increased grid conversion efficiency; for CdTe PV operating in south California with grid conversion efficiency of 49%, the EROI is about 50 and is projected to fall to 30 when the state's 2030 target of 80% renewable energy penetration materializes. Material alternatives that show a potential of further reductions in degradation rates and materials for enhanced encapsulation that would enable longer operation lives have also been investigated. A degradation rate of 0.3%/year, which has been verified by accelerated testing, is assumed in 30-year scenarios; this is projected to be reduced to 0.2%/year in the near-term and potentially to 0.1%/year in the longer term. With such low degradation rates and enhanced edge-sealing, modules can last 40- to 50-years. Consequently, all impact indicators will be proportionally reduced while EROI will increase. This detailed LCA was conducted according to ISO standards and IEA PVPS Task 12 guidelines. Furthermore, the study revealed that the choices of system models, methods and temporal system boundaries can significantly impact the results and points out to the need to include assumptions regarding these choices in the “transparency in reporting” requirements listed in the IEA PVPS Task 12 Guidelines.